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Hyperosmolarity is a feature common to many cases of 
dry eye disease, although there is sometimes a lack of correla-
tion in studies between other dry eye tests and osmolality 
measurements of the tear film. Hyperosmolarity can result 
from either a decrease in tear secretion or an increase in tear 
evaporation—the two pathways that produce ocular dryness 
[1,2]. Tear osmolarity measured from the lower meniscus 
of tears of patients with dry eye can reach values of up to 
360 mOsm [3,4] compared with 300–310 mOsm in normal 
eyes [5-7]. However, the osmolarity measured from the lower 
meniscus might not fully reflect osmolarity over the ocular 
surface. Although measuring the osmolarity directly over the 
ocular surface has remained technically challenging, it has 
been proposed that the tear film osmolarity in these regions 
can increase to 450 to 600 mOsm [8-10].
Tear hyperosmolarity is the central mechanism in the 
pathogenesis of ocular surface damage and is associated with 
inflammation in dry eye disease [2,11]. An increase in tear 
osmolarity has also been found to correlate with the severity 
of dry eye disease across normal, mild/moderate, and severe 
categories [12]. Hyperosmolarity-associated ocular surface 
damage and inflammation have been widely demonstrated 
in studies using animal dry eye models [13-16] as well as in in 
vitro human corneal epithelial cell culture models [17,18]. Tear 
hyperosmolarity can damage the surface epithelium, which 
can trigger production of signaling molecules, including 
various interleukins, tumor necrosis factor, and matrix metal-
loproteinases [13,14,17,19], as well as decrease the number of 
conjunctival goblet cells, which results in a disturbance of 
mucin expression leading to tear instability and subsequent 
increases in the ocular surface osmolarity, thus perpetuating 
the inflammatory cycle [20,21]. Although a direct relationship 
between high tear osmolarity and ocular surface damage has 
not been firmly established in human subjects, Reinoso et al. 
demonstrated significantly increased apoptosis levels in the 
conjunctival epithelium of patients with evaporative dry eye 
disease compared with normal eyes [22].
Exposure of the ocular surface to a hyperosmotic 
environment causes an imbalance between the extracel-
lular and intracellular compartments resulting in net efflux 
of water from the ocular surface epithelial cells leading 
to cell shrinkage [17,18,23]. Excessive alterations in cell 
volume impinge upon cell survival, interfering with the cell 
membrane, cytoskeletal integrity, and cytosolic proteins 
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Decrease in hyperosmotic stress–induced corneal epithelial cell 
apoptosis by L-carnitine
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Purpose: To characterize the osmoprotective properties of L-carnitine on human corneal epithelial cell volume and 
apoptosis during hyperosmotic stress.
Methods: Human corneal limbal epithelial (HCLE) cells were exposed to culture medium at 300 mOsm (isotonic) or 
500 mOsm (hyperosmotic) with or without L-carnitine (10 mM). Induction of apoptosis was detected by quantifying 
the proteolytic activity of caspase-8, caspase-9, and caspase-3/7 using caspase activity assays, the expression of tumor 
necrosis factor (TNF)-α with enzyme-linked immunosorbent assay, and annexin V/propidium iodide staining of HCLE 
cells evaluated with confocal microscopy and flow cytometry. Cell volume changes in response to hyperosmotic stress 
were analyzed using flow cytometry.
Results: After the HCLE cells were exposed to hyperosmotic medium (500 mOsm), the percentage of shrunken cells 
and damaged/dead cells (stained positively for annexin V and/or propidium iodide) was six- and three-fold, respectively, 
higher than that under isotonic conditions (300 mOsm). This was paralleled by an increase in TNF-α concentration in 
media and caspase-8, -9, and -3/7 activities (six-, four-, ten-, and twelve-fold, respectively; all showing p<0.001). Addi-
tion of L-carnitine during hyperosmotic stress partly restored cell volume and significantly reduced the concentration 
of TNF-α released (p=0.005) and caspase-9 activity (p=0.0125). Addition of L-carnitine reduced the percentage of 
hyperosmolarity-induced damaged/dead cells to levels observed under isotonic conditions.
Conclusions: L-carnitine can regulate human corneal epithelial cell volume under hyperosmotic stress and ameliorate 
hyperosmotic stress–induced apoptosis.
Correspondence to: Qian Garrett, Brien Holden Vision Institute, 
Level 4, Rupert Myers Building, The University of New South 
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[24]. To counteract these harmful effects, the cells respond 
through an immediate intracellular influx and accumulation 
of components including inorganic ions through activation 
of ion transporters, exchangers, or channels, which helps to 
equilibrate osmolality and thus regulate cell volume [24]. 
The survival of hypertonicity-stressed corneal epithelial 
cells depends on Na+ K+ 2Cl- cotransporter (NKCC) activity, 
which is controlled by p38 mitogen-activated protein kinase 
(MAPK) activation [25-27]. However, the accumulation of 
inorganic ions in cells can interfere with normal cellular 
processes and cause precipitation of cell macromolecules, 
denaturation and destabilization of internal proteins, altera-
tions in membrane potentials, and changes in the rates of 
enzymatic reactions, leading to premature cell death [24,28-
32]. Hyperosmolarity-induced apoptosis in cultured human 
ocular surface epithelial cells has been reported [33-35].
Cells can adapt to the hyperosmotic environment by 
taking up organic osmolytes (also known as osmoprotectants) 
[36], which, unlike inorganic ions, do not interfere with cell 
metabolism or destabilize proteins, thus protecting against 
cellular damage and helping cells survive and function [37]. 
L-carnitine is a naturally occurring amino acid best known 
for its role in the mitochondrial oxidation of long chain fatty 
acids [38]. Carnitine also participates in cell volume and 
fluid balancing in all tissues affected by the tonicity (iso-, 
hyper-, hypotonicity) of the extracellular environment [39]. 
In the kidney, osmolytes including carnitine are crucial in 
maintaining cell volume in an environment of drastically 
fluctuating tonicity resulting from fluctuations in increased 
production of urine and antidiruesis. The resulting increased 
extracellular osmolarity of medullary cells can be more 
than four-fold that of isotonicity [40-42]. In the brain, the 
role of carnitine in isotonicity is crucial since alteration of 
tonicity affects nerve excitability due to ion fluctuation, 
and brain cells cannot swell due to skull rigidity [39]. In 
the ocular system, Corrales and colleagues [17] reported 
that under hyperosmolar conditions, L-carnitine protects 
cultured human corneal epithelial cells through its inhibition 
of hyperosmolarity-induced activation of mitogen-activated 
protein (MAP) kinases although the nature of the potential 
interaction of L-carnitine with signaling pathways for MAP 
kinases has not been explored. L-carnitine also protects rabbit 
corneal epithelial cells from hyperosmotic stress in dry eye 
models [43]. L-carnitine can also limit progression and reduce 
the severity of mouse dry eye with demonstrated reduction 
in corneal staining and several apoptotic epithelial cells [44]. 
In mammals, carnitine, obtained by in situ biosynthesis and 
from the diet [45], is maintained at a steady-state concen-
tration in many tissues such as skeletal and heart muscles, 
principally by the organic cation transporter (OCT) system, 
specifically by OCTN1 and OCTN2 [46-48].
Previous studies demonstrated the presence of OCTN1 
and OCTN2 in human and rabbit corneal and conjunctival 
epithelial cells [49]. These transporters are upregulated under 
hyperosmotic stress [49]. The level of L-carnitine in tears 
is depleted during dry eye [50], and there are reports that 
administering L-carnitine to the ocular surface improves the 
common signs and symptoms of dry eye and reduces dry 
eye–associated conjunctival staining [51].
In this study, we used an in vitro human corneal-limbal 
epithelial (HCLE) culture model to determine the osmopro-
tective properties of L-carnitine through its ability to regulate 
hyperosmolarity-induced cell volume changes and apoptosis 
characterized by the proteolytic activity of caspase-8, 
caspase-9, and caspase-3/7 and the release of tumor necrosis 
factor (TNF)-α. We provide evidence demonstrating that 
L-carnitine can aid in maintaining cell volume under hyper-
osmotic stress and ameliorate certain aspects of hyperosmotic 
stress-induced apoptosis.
METHODS
Cell culture: An immortalized HCLE cell line derived from 
primary cultures of HCLE cells (a kind gift from Dr. Ilene 
Gipson, Schepens Eye Research Institute, Boston, MA) was 
used in the study. Cells were maintained at 2×104/cm2 in a 
keratinocyte serum-free medium (K-SFM; Invitrogen-Gibco, 
Grand Island, NY), supplemented with 25 μg/ml bovine 
pituitary extract, 0.2 ng/ml epidermal growth factor (EGF; 
Invitrogen, Mount Waverley, Australia), and 0.4 mM CaCl2, 
and grown at 37 °C in a 5% carbon dioxide atmosphere. To 
enhance nutrient composition, the cultures were switched at 
approximately 50% confluence to a 1:1 mixture of K-SFM and 
low calcium Dulbecco’s Modified Eagle Medium (DMEM)/
F12 medium (Invitrogen) to achieve confluence. For the 
influence of Ca2+ on the cellular response to hyperosmolar 
stress and the effect of L-carnitine, cells were transferred to a 
1:1 mixture of K-SFM and 1.0 mM Ca2+ DMEM/F12 medium 
to achieve confluence.
Exposure of human corneal-limbal epithelial cells to hyper-
osmotic conditions in the presence of L-carnitine: A hyperos-
molar medium of 500 mOsm was achieved with the addition 
of NaCl. Osmolality was confirmed using a Vapro 5520 vapor 
pressure osmometer (Wescor, Logan, UT). HCLE cells with 
70%–80% confluence were exposed to isotonic (300 mOsm) 
or hypertonic media (500 mOsm) in the presence or absence 
of 10 mM L-carnitine [17] or 10 mM D-carnitine (as a 
comparison), for 16 h at 37 °C. The osmolarity and exposure 
time were established previously, based on our preliminary 
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evidence indicating that the osmolarity of 500 mOsm and an 
exposure time of 16 h were optimal for studying measurable 
cellular responses [52].
Caspase activity assay: Luminescent assay kits (Promega, 
Madison, WI) were used to measure the proteolytic activity 
of caspase-8, caspase-9, and caspase-3/7. The assays were 
performed according to the manufacturer’s instructions. 
Brief ly, 100 µl of caspase-8, caspase-9, or caspase-3/7 
luminogenic substrate reagents were added individually to 
HCLE cells after 16 h exposure to isotonic or hyperosmotic 
medium in the presence or absence of 10 mM L-carnitine. 
The reagents and cells were incubated at room temperature 
for 1 h after which the luminescence was measured using 
a Tecan SpectraFluor Plus 137 microplate reader (Tecan, 
Männedorf, Switzerland).
Measurement of tumor necrosis factor-α production: Produc-
tion of TNF-α by HCLE cells in the culture supernatants was 
evaluated using enzyme-linked immunosorbent assay (R&D 
Systems, Minneapolis, MN) according to the manufacturer’s 
instructions. The culture supernatants were collected, centri-
fuged at 239 ×g for 5 min to remove the detached cells, and 
stored at −80 °C until processed. Absorbance was measured 
at 540 nm using a Multiskan spectrum spectrophotometer 
(Thermo Scientific, Vic, Australia)
Confocal microscopic evaluation of human corneal-limbal 
epithelial cells: Apoptosis or necrosis in HCLE cells was 
monitored with the Alexa Fluor 488 annexin V/propidium 
iodide (PI) assay (Vybrant apoptosis assay kit; Invitrogen, 
Australia) using a confocal microscope (FluoView FV1000 
confocal laser scanning microscopy; Olympus, Tokyo, Japan). 
HCLE cells were seeded at a concentration of 6.5×104 cells/
ml in 75 cm2 cell culture flasks, and 70%–80% confluent 
cells were subjected to 300 mOsm and 500 mOsm media 
with and without 10 mM L-carnitine for 16 h. Total cells 
(the detached cells were collected after the media were spun 
at 239 ×g for 5 min and the remaining adherent cells were 
collected with trypsinization) were then stained with Alexa 
Fluor 488 Annexin V (5 µl/100 µl), Hoechst 33342 (12.5 µg/
ml), and PI (1 µg/ml) for 15 min at room temperature, and 
washed with annexin-binding buffer (Invitrogen, Australia) 
before the confocal microscopic evaluation. Images of five 
different fields of view for each sample (three samples per 
treatment) were captured, and cells were quantified using 
ImageJ (National Institutes of Health, Bethesda, MD).
Flow cytometry analysis of human corneal-limbal epithelial 
cell responses: Cell apoptosis or necrosis was further evalu-
ated using an Attune Acoustic focusing flow cytometer (Life 
Technologies Applied Biosystems, Vic, Australia). Vybrant 
cell apoptosis kit (Invitrogen, Australia) containing annexin 
V and PI was used to analyze the physiologic state of the 
cells in response to 16 h exposure to isotonic (300 mOsm) 
or hypertonic (500 mOsm) conditions with or without 
10 mM L-carnitine or D-carnitine. Staining was performed 
according to the manufacturer’s instructions. Annexin V 
and PI staining was evaluated using the blue/violet laser at 
excitation/emission of 480/500 nm (20 mW) and the blue/
red laser at excitation/emission of 490/635 nm, respectively. 
Based on the principle that the forward scatter of the laser 
light produced by the flow cytometer is proportional to the 
volume of the cell, while the side scatter represented cells 
with greater structural complexity and granularity and thus 
a shrunken cell [53], the cell volume changes in response to 
isotonic (300 mOsm) or hyperosmotic (500 mOsm) challenge 
with or without 10 mM L-carnitine (16 h) were evaluated 
using flow cytometry by gating populations such that the 
cells with greater forward scatter constituted the percentage 
of cells with intact cell volume while those showing greater 
side scatter comprised the shrunken cell population.
Data analysis: All results are presented as mean±standard 
deviation (SD). Group means were compared using one-way 
analysis of variance (ANOVA) with Bonferroni correction. 
The Student t test was performed to compare data comprising 
two groups at the p<0.05 level of significance.
RESULTS
Caspase activity in response to hyperosmotic stress in the 
presence of L-carnitine: When exposed to the hyperosmotic 
medium (500 mOsm) for 16 h, the activity of caspase-8, -9, 
and -3/7 were increased significantly (each with p<0.001) 
with approximately four-, ten-, and twelve-fold of the value 
of isotonic cells, respectively (Figure 1). Adding L-carnitine 
(10 mM) during hyperosmotic stress suppressed elevation 
of caspase-9 activity significantly (Figure 1A; p=0.0125). 
However, no significant effect was observed for L-carnitine 
on caspase-8 (Figure 1B) and caspase-3/7 (Figure 1C).
Tumor necrosis factor-α production in response to hyper-
osmotic stress in the presence of L-carnitine: Exposure of 
HCLE cells to 500 mOsm media resulted in a significant 
increase in TNF-α production (six-fold, p<0.001). This 
increase was counteracted significantly but not fully by the 
addition of L-carnitine during the hyperosmotic exposure 
(p=0.005; Figure 2).
Induction of cell apoptosis by hyperosmotic stress in the pres-
ence of L-carnitine: When the HCLE cells were exposed to 
isotonic (300 mOsm) media, confocal microscopic evaluation 
revealed a dominant population of healthy cells (Figure 3A), 
blue cells stained positive with Hoechst 33342 but not with 
annexin V or PI. Hyperosmotic stress (500 mOsm) resulted in 
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an increase in the proportion of damaged/dead cells composed 
of early apoptotic (green: positive annexin V staining); late 
apoptotic [yellow: positive annexin V (green) + positive PI 
staining (red)]; and necrotic (red: positive PI staining) cells 
(Figure 3B). Adding L-carnitine to the hyperosmolar medium 
resulted in a significant decrease in the number of damaged/
dead cells (i.e., those stained with annexin V and/or PI; 
p<0.05; Figure 3C,D).
After the cells were transferred to higher calcium-
containing media, confocal microscopic evaluation revealed 
a heterogeneous mixed population of differentiated and 
undifferentiated cells (data not shown). After the cells were 
exposed to hyperosmotic medium (500 mOsm) in the pres-
ence of 1.0 mM Ca2+, the percentage of apoptotic and necrotic 
cells increased significantly (p=0.0001). With addition of 
10 mM L-carnitine, however, a significant reduction in the 
percentage of apoptotic and necrotic cells was observed 
compared to that without treatment with L-carnitine (Figure 
3E). These results were similar to that observed when the 
cells were cultured under low Ca2+concentration (0.4 mM; 
Figure 3D), suggesting that L-carnitine is also effective for 
more differentiated cells.
Further analysis using f low cytometry (Figure 4) 
indicated the percentage of apoptotic and necrotic cells 
(Figure 4A, quadrants b, c, d) was comparatively high under 
hyperosmotic stress (500 mOsm) compared to the isotonic 
control (300 mOsm), and was visibly reduced after 10 mM 
Figure 1. Activity of caspase-9 (A), caspase-8 (B), and caspase-3/7 (C) during isotonic (300 mOsm) or hyperosmotic (500 mOsm) stress in the 
presence or absence of L-carnitine (10 mM). Data are shown as the percentage mean±SD (n=6) over the isotonic medium group (300 mOsm). 
* shows the significant difference between cells treated with and without L-carnitine during exposure to 500 mOsm medium osmolarity. # 
shows the significant difference from 300 mOsm medium.
Figure 2. Production of tumor 
necrosis factor-α by human corneal-
limbal epithelial cells in response 
to isotonic (300 mOsm) or hyper-
osmotic stress (500 mOsm) with or 
without carnitine (10 mM) for 16 h. 
Data represent the mean±SD of five 
samples. * shows the significant 
difference between cells treated 
with and without L-carnitine 
during exposure to 500 mOsm 
medium osmolarity. # shows the 
significant difference from 300 
mOsm medium.
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L-carnitine was added, but not D-carnitine, to the hyperos-
molar media (500 mOsm; Figure 4A).
Further statistical analysis showed that the percentage of 
damaged (apoptotic and necrotic) cells when the cells were 
exposed to hyperosmolar medium increased significantly 
from 7% in 300 mOsm to 33% in 500 mOsm (p=0.0014; 
Figure 4B). In the presence of L-carnitine, the percentage 
of hyperosmolar medium (500 mOsm)–induced apoptotic 
and necrotic cells was reduced significantly to approach 
that under isotonic conditions (from 33% to 13%, p=0.0294; 
Figure 3. Confocal microscopic evaluation of hyperosmotic stress in the presence of 10 mM L-carnitine on the physiological state of HCLE 
cells. Representative images of HCLE cells stained with Hoechst (blue), annexin V (green) and PI (red) after 16 h exposure to 300 mOsm 
(A), 50 mOsm (B) or 500 mOsm+10 mM L-carnitine (C) media are shown. These images were acquired under the normal culture condition 
for HCLE with Ca2+ concentration of 0.4 mM.The percentage of healthy and damaged/dead HCLE cells under the Ca2+ concentration of 0.4 
mM (D) or 1.0 mM (E) is shown. * and # represents a statistically significant difference between 500 mOsm and 500 mOsm+L-carnitine or 
isotonic (300 mOsm) conditions with Ca2+ concentration of 0.4 and 1.0 mM, respectively. 
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Figure 4B). There was no statistically significant difference in 
the percentage of damaged cells in response to the exposure 
to hyperosmotic medium with or without the presence of 
D-carnitine (p>0.05; Figure 4B).
Figure 4. Flow cytometry analysis of the physiologic state of cells in response to isotonic (300 mOsm) media or hyperosmotic stress (500 
mOsm) in the presence or absence of L-carnitine or D-carnitine (10 mM). A: Representative flow cytometry dot plots are shown. Quadrant 
‘a’=the population of viable healthy cells that stained with neither propidium iodide (PI) nor annexin V. Quadrant ‘b’=the population of cells 
staining with annexin V but not PI, indicating an early apoptotic population. Quadrant ‘c’=the population of cells stained with annexin V 
and PI, indicating a late apoptotic population. Quadrant ‘d’=the population of cells staining positive for PI but not annexin V, indicating the 
complete loss of the cell membrane and thus representing necrotic cells. B: Statistical analysis of percentage of healthy and damaged/dead 
HCLE cells is shown. Data represent the mean±SD of eight samples. * represents the statistically significant difference between 500 mOsm 
and 500 mOsm + L-carnitine or isotonic (300 mOsm). 
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L-carnitine modulation of cell volume: Flow cytometry anal-
ysis was used to determine cell volume changes in response 
to hyperosmolarity with or without L-carnitine. Figure 5A 
shows the population of cells with compromised cell volume 
(i.e., shrunken cells) in the presence of 500 mOsm media 
compared to those under isotonic conditions (300 mOsm). 
The percentage of shrunken cells increased from 5% to 31% 
(p=0.0012; Figure 5B) in the presence of the hyperosmolar 
media. When the cells were supplemented with L-carnitine 
during hyperosmotic stress, the percentage of hyperosmotic 
stress–induced shrunken cells decreased significantly 
from 31% to 11% (p=0.0169; Figure 5B). The percentage 
of shrunken cells after treatment with 500 mOsm + 10mM 
L-carnitine was not significantly different from that for the 
control 300 mOSm treatment (p>0.05; Figure 5B). Adding 
D-carnitine to hyperosmotic medium had little effect on the 
percentage of shrunken cells compared to that in the absence 
of D-carnitine (Figure 5).
DISCUSSION
Tear hyperosmolarity is a central factor in dry eye–related 
ocular surface damage, inflammation, and symptoms [11]. 
The key new finding of this study is that cultured human 
corneal epithelial cells can adapt to hyperosmotic stress by 
partially restoring the cell volume through uptake of a compat-
ible osmolyte, L-carnitine, and to counteract the deleterious 
effects of hyperosmolarity (500 mOsm). L-carnitine regulated 
the volume of HCLE cells under hyperosmotic conditions, 
eliciting a concomitant reduction in the caspase cascade that 
is an inducer of apoptosis. Incubating HCLE in hyperosmolar 
media resulted in an increased number of shrunken, apoptotic 
and necrotic HCLE cells, accompanied by increased produc-
tion of TNF-α and elevated activity levels of caspases-3/7, -8. 
Figure 5. Flow cytometry evaluation of human corneal-limbal epithelial (HCLE) cell volume changes in response to isotonic (300 mOsm) 
medium or hyperosmotic medium (500 mOsm) with or without the presence of L-carnitine or D-carnitine (10 mM). A: Representative dot 
plots, (a) population of healthy cells and (b) population of shrunken cells, are shown. B: Percentage number of healthy and shrunken HCLE 
cells is shown. Data represent the mean±SD of eight samples. * shows the significant difference in the percentage number of shrunken cells 
between 500 mOsm and 500 mOsm + L-carnitine or isotonic (300 mOsm). 
Molecular Vision 2013; 19:1945-1956 <http://www.molvis.org/molvis/v19/1945> © 2013 Molecular Vision 
1952
and -9. Osmotic shrinkage acting as a signal to apoptosis has 
been observed in various cell types including human corneal 
epithelial cells [33-35,54,55]. A link between hyperosmotic 
stress and the induction of apoptosis in cultured human 
ocular surface epithelial cells has been established by several 
researchers [33-35]. Proposed pathways include the release of 
cytochrome c from mitochondria that then triggers activation 
of c-Jun N-terminal kinase, extracellular signal-regulated 
kinase mitogen-activated protein kinase, and caspase 3 [33] 
and activation of polo-like kinase 3 (Plk3) [18]. Alternative 
proposals include a caspase-independent pathway through the 
translocation of apoptosis-inducing factor from the mitochon-
dria to the nucleus where apoptosis-inducing factor binds to 
DNA and leads to chromatin condensation and cell death [34].
The caspase family plays an important role in apoptosis. 
Two major pathways have been identified for induction of 
apoptosis [56,57]. One involves participation of the TNF 
family of receptors characterized by so-called death domains 
on their cytoplasmic tails. The ligation of death receptors by 
their ligands activates caspase-8. The other pathway involves 
the participation of mitochondria, which releases cytochrome 
c to activate caspase-9. Caspases-8 and -9 subsequently acti-
vate the downstream effector caspases, such as caspase-3/7, 
which are responsible for the proteolytic cleavage of a broad 
spectrum of cellular targets ultimately leading to cell death. 
In the present work, the activity of caspase-8, -9, and -3/7 of 
the HCLE cells subjected to 500 mOsm for 16 h increased 
significantly, compared to the value of isotonic cells. These 
data suggest that the mitochondria and death receptor path-
ways might be involved in the hyperosmolarity-induced 
apoptosis of HCLE cells.
TNF-α is a potent cytokine produced by many cell types 
including human corneal epithelial cells [58,59]. TNF-α is 
induced via activation of nuclear factor of activated T-cell-5 
(NFAT-5), an important tonicity response gene regulator 
and survival factor in hyperosmolar stressed human limbal 
epithelial cells [27]. TNF-α elicits a broad spectrum of cellular 
responses, including cell proliferation, differentiation, and 
apoptosis [60,61]. TNF-α triggers apoptosis by binding to 
the TNF-α receptor and subsequently activates caspase-8 
[62], which forms a death-signaling complex with tumor 
necrosis factor receptor type 1-associated death domain 
protein (TRADD), and Fas-associated protein with death 
domain (FADD) that can further induce effector caspases 
such as caspase-3/7 causing initiation of apoptosis [63,64]. In 
agreement with others [55,58], we also observed the induction 
of TNF-α expression by hyperosmotic stress, and we found 
the increased TNF-α expression was associated with the 
increased population of apoptotic/necrotic cells subjected to 
prolonged exposure to hypersomotic stress.
Many types of cells respond to extracellular hyperos-
molarity by the accumulation of organic osmolytes, such as 
taurine and betaine, which protect cells from the perturbing 
effects of high extracellular concentrations of electrolytes 
[65-68]. A role for L-carnitine as a stress protectant has been 
described in which L-carnitine protects against stress acti-
vation of MAP kinases in cultured corneal epithelial cells 
[17]. Previous studies have shown that HCLE cells have the 
specific transporters OCTN1 and OCTN2 for L-carnitine [49] 
and the uptake of L-carnitine is Na+-dependent [69], which 
suggests that the uptake of L-carnitine by HCLE cells might 
be facilitated in a hyperosmolar environment similar to that 
of other osmoprotectants such as betaine and taurine whose 
uptake can be facilitated and increased under hyperosmolar 
conditions [66,69]. Although L-carnitine uptake by corneal 
epithelial cells appeared to be maximal at 0.5 mM under 
iso-osmolar conditions [69], 10 mM L-carnitine was used in 
the present study to ensure an excess of L-carnitine in the 
hyperosmolar culture medium (500 mM). Other researchers 
have also shown that L-carnitine at 10 mM is effective as an 
osmoprotectant for human primary corneal epithelial cells 
[17]. In the present study, we demonstrated that HCLE cells 
in the presence of L-carnitine reduced the hyperosmolarity-
induced cell shrinkage and subsequent cell apoptosis, there-
fore enabling increased survival under conditions of high 
(external) osmolarity.
L-carnitine is a zwitterionic molecule. Unlike many 
other zwitterionic amino acids that are active participants in 
cellular metabolism and thus the intracellular concentrations 
required for their effective osmoprotection are impossible 
to achieve, L-carnitine is not typically metabolized [39] 
and has been demonstrated to act as an osmoprotectant in 
various mammalian systems and bacteria [39,70-72]. We 
characterized the properties of L-carnitine as an osmopro-
tectant particularly in restoring cell volume and protection 
against hyperosmolarity-induced cell apoptosis. L-carnitine’s 
ability to regulate hyperosmolarity-induced cell volume 
changes might be one of the underlying mechanisms by 
which L-carnitine suppresses the initiation of hyperosmotic 
stress-induced apoptosis, and contributes to the survival of 
cells, although not fully, under hyperosmolar conditions. 
D-carnitine (known to be biologically inactive [73]), however, 
did not exhibit similar osmoprotection activity. D-carnitine’s 
inability to stabilize cell volume under hyperosmotic stress 
corresponded with the observation of a lack of protection 
for cells under hyperosmotic stress, further supporting the 
mechanism of action for L-carnitine as an osmoprotectant: 
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regulate cell volume under hyperosmotic stress and amelio-
rate hyperosmotic stress–induced cell apoptosis.
L-carnitine is antiapoptotic [74,75] and antioxidative 
[76], protects Jurkat cells against Fas-mediated apoptosis, 
and is a potent inhibitor of caspase-3 [77]. L-carnitine 
inhibits the oxidative stress-induced activation of caspase-3 
in a dose-dependent manner [76]. Carnitine also reduces 
the quantity of oxidant-induced cytosol cytochrome c and 
increases antiapoptotic Bcl-xL expression, resulting in 
protection of cardiomyocytes from doxorubicin-induced 
apoptosis [74]. We found that adding L-carnitine significantly 
reduced the activity of caspase-9 presumably not directly but 
as the result of preventing activation in HCLE cells during 
hyperosmotic stress. Further, L-carnitine also inhibits 
Fas-induced apoptosis [78], which can lead to inhibition of 
caspase-8 [77]. Interestingly, we found L-carnitine inhibited 
hyperosmolarity-induced TNF-α expression but showed little 
effect on the activity of caspase-8 under the study conditions. 
Caspase-8 is best characterized as the principal upstream 
caspase of death receptor signaling, and evidence indicates 
caspase-8 is implicated in non-receptor-mediated apoptosis 
[79]. In some cell types, lack of caspase-8 does not protect 
completely from TNF-induced cell death. TNF-α signaling 
uses caspase effectors in addition to caspase-8 [79].
Therefore, we speculate that the extrinsic caspase-8 
dependent pathway might play a minor role for HCLE cells at 
times of hyperosmotic stress, at least in vitro under our study 
conditions where 10 mM L-carnitine was tested. Whether 
this concentration is optimal for studying the interactions of 
L-carnitine with caspase pathways has yet to be determined, 
and further investigation is needed to determine the precise 
mechanism of cell death that results from hyperosmolar 
stress on corneal epithelial cells and the role of L-carnitine 
protection from cell death. In conclusion, the present study 
confirmed that L-carnitine can regulate human corneal 
epithelial cell volume under hyperosmotic stress and amelio-
rate the initiation of hyperosmotic stress-induced apoptosis.
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